论文部分内容阅读
目的:探究与分析慢性气管炎的临床治疗效果。方法:选取我所自2011年6月至2014年6月门诊治疗的56例慢性气管炎患者,将其作为临床研究对象,采取随机数字表法分为对照组与试验组,每组各28例。对照组给予左氧氟沙星片联合氨茶碱片治疗,试验组在其基础上加用盐酸氨溴索口服溶液治疗,观察与对比两组患者的临床疗效及不良反应发生率。结果:对照组经过治疗后总有效19例,占67.86%,试验组经过治疗后总有效26例,占92.86%。试验组与对照组的总有效率相比差异具有统计学意义(χ~2=4.56,P<0.05)。对照组经过治疗后总并发症6例,总并发症发生率为21.43%,试验组经过治疗后总并发症5例,总并发症发生率为17.86%。试验组与对照组的总并发症发生率相比差异无统计学意义(χ~2=2.77,P>0.05)。结论:在采用左氧氟沙星联合氨茶碱片的基础上加用盐酸氨溴索口服液治疗慢性气管炎的临床疗效显著,不良反应较少,安全性较高,值得基层推广。
Objective: To explore and analyze the clinical effect of chronic bronchitis. Methods: Fifty-six patients with chronic bronchitis who were treated in our hospital from June 2011 to June 2014 were selected as the clinical study subjects and divided into control group and experimental group by random number table method, with 28 cases in each group . The control group was given levofloxacin tablets combined with aminophylline tablets. The experimental group was treated with Ambroxol Hydrochloride oral solution. The clinical efficacy and the incidence of adverse reactions were observed and compared between the two groups. Results: The control group after treatment, the total effective 19 cases, accounting for 67.86%, the experimental group after treatment, the total effective 26 cases, accounting for 92.86%. The total effective rate of the experimental group and the control group was statistically significant (χ ~ 2 = 4.56, P <0.05). The control group after treatment, the total complication in 6 cases, the total complication rate was 21.43% in the experimental group after treatment, the total complication in 5 cases, the total complication rate was 17.86%. There was no significant difference in the incidence of total complication between experimental group and control group (χ ~ 2 = 2.77, P> 0.05). Conclusion: The combination of levofloxacin and aminophylline tablets based on the addition of ambroxol hydrochloride oral liquid for the treatment of chronic bronchitis significant clinical effects, fewer adverse reactions, higher safety, it is worth promoting the grassroots.